Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Subjects
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
To assess the safety and tolerability of ascending single oral doses of SAM-531 in healthy
subjects.To obtain preliminary pharmacokinetic (PK) and pharmacodynamic (PD) profiles of
SAM-531, an investigational drug, in healthy subjects and to evaluate the effect of a
high-fat meal on the PK of SAM-531 administered to healthy subjects.